Holen Sie sich die Stockscreener-App
9.185
0.27%
0.025
Schlusskurs vom Vortag:
$9.16
Offen:
$9.21
24-Stunden-Volumen:
29,931
Relative Volume:
0.32
Marktkapitalisierung:
$93.07M
Einnahmen:
$75.67M
Nettoeinkommen (Verlust:
$-31.15M
KGV:
-33.08
EPS:
-0.2777
Netto-Cashflow:
$-39.79M
1W Leistung:
-0.05%
1M Leistung:
+0.38%
6M Leistung:
-22.53%
1J Leistung:
-40.55%
1-Tages-Spanne:
$9.15
$9.22
1-Wochen-Bereich:
$9.12
$9.28
52-Wochen-Spanne:
$4.815
$20.02
Optinose Inc Stock (OPTN) Company Profile
Firmenname
Optinose Inc
Sektor
Telefon
267-364-3500
Adresse
777 TOWNSHIP LINE ROAD, YARDLEY, PA
Vergleichen Sie OPTN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPTN
Optinose Inc
|
9.19 | 93.07M | 75.67M | -31.15M | -39.79M | -0.2777 |
|
ZTS
Zoetis Inc
|
149.45 | 66.56B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.45 | 45.61B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.93 | 15.25B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
291.25 | 12.79B | 2.76B | 1.11B | 898.10M | 22.77 |
Optinose Inc Stock (OPTN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-20 | Herabstufung | Lake Street | Buy → Hold |
| 2025-01-03 | Bestätigt | H.C. Wainwright | Buy |
| 2024-03-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-08-21 | Eingeleitet | Lake Street | Buy |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-12-18 | Eingeleitet | Cowen | Outperform |
| 2018-08-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Optinose Inc Aktie (OPTN) Neueste Nachrichten
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: The AZEK Company Inc. (NYSEAZEK), Mesa Air Group, Inc. (NasdaqMESA), Mr. Cooper Group Inc. (Nasdaq – COOP), Optinose, Inc. (NasdaqOPTN) - Morningstar
After Fielding Multiple Offers, Yardley-Based Optinose Secures Potential $330M Deal With Paratek - BUCKSCO.Today
How a Bucks County firm's multiyear pursuit of a partner led to a potential $330M deal - The Business Journals
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COOP, MESA on Behalf of Shareholders - The Malaysian Reserve
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Intranasal Drug Delivery Devices Market Projected To Witness - openPR.com
When (OPTN) Moves Investors should Listen - news.stocktradersdaily.com
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The MergerOPTN, SLRN, AKYA, SHYF - Lelezard
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN - Bluefield Daily Telegraph
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF - GlobeNewswire Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HMST, COOP, OPTN, RDFN on Behalf of Shareholders - The Malaysian Reserve
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mr. Cooper Group Inc. (Nasdaq – COOP), Beacon Roofing Supply, Inc. (NasdaqBECN), Optinose, Inc. (NasdaqOPTN), Redfin Corporation (NasdaqRDFN - TradingView
Bank of New York Mellon Corp Sells 170,507 Shares of OptiNose, Inc. (NASDAQ:OPTN) - Defense World
Optinose Reports 2024 Financial Results, Highlights Prescription Growth and First Operational Income - MyChesCo
OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates - MSN
OptiNose earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights - GlobeNewswire
OptiNose: Q4 Earnings Snapshot - The Washington Post
OPTINOSE Earnings Results: $OPTN Reports Quarterly Earnings - Nasdaq
OptiNose Q4 Net Loss Narrows - Nasdaq
OptiNose Q4 Income From Operations USD 354 Thousand - MarketScreener
OptiNose Inc. Q4 Loss Decreases, Beats Estimates - Nasdaq
Philly weekly roundup: Proscia's $50M raise; Optinose acquired; A new biotech startup incubator - Technical.ly
Wall Street Analysts Believe OptiNose (OPTN) Could Rally 143.06%: Here's is How to Trade - Yahoo Finance
Paratek Pharmaceuticals’ Acquisition of Optinose - Global Legal Chronicle
Piper Sandler Reaffirms Neutral Rating for OptiNose (NASDAQ:OPTN) - Defense World
HC Wainwright Reaffirms Neutral Rating for OptiNose (NASDAQ:OPTN) - Defense World
OptiNose (NASDAQ:OPTN) Cut to “Hold” at Piper Sandler - Defense World
OptiNose (NASDAQ:OPTN) Rating Lowered to “Hold” at Lake Street Capital - Defense World
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc.OPTN - Business Wire
Earnings To Watch: OptiNose Inc (OPTN) Reports Q4 2024 Result - GuruFocus
OPTN Stock Soars 53% on Inking $330M Deal to be Acquired by Paratek - MSN
Paratek Pharmaceuticals Acquires Yardley-Based Optinose in $330M Deal - BUCKSCO.Today
This FedEx Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga
Further Upside For OptiNose, Inc. (NASDAQ:OPTN) Shares Could Introduce Price Risks After 56% Bounce - Simply Wall St
Why OptiNose Inc. (OPTN) Surged On Thursday? - Insider Monkey
ProAssurance (PRA) and Optinose (OPTN) soar on M&A news - Investorsobserver
Darden Restaurants, Nike, Optinose - TradingView
10 Micro-, Small-Cap Firms Dominate Thursday’s Gains - Insider Monkey
Lake Street cuts Optinose stock rating, lowers target to $9 By Investing.com - Investing.com Australia
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of OptiNose, Inc.OPTN - The Malaysian Reserve
Paratek To Acquire Optinose, Expanding Portfolio Beyond Antibiotics - insights.citeline.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, BECN, OPTN on Behalf of Shareholders - The Malaysian Reserve
Sector Update: Health Care Stocks Mixed in Afternoon Trading -March 20, 2025 at 02:03 pm EDT - Marketscreener.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Beacon Roofing Supply, Inc. (Nasdaq – BECN), Optinose, Inc. (Nasdaq – OPTN), Corporation (Nasdaq – RDFN), Blackboxstocks Inc. (Nasdaq – BLBX) - TradingView
Optinose Shares Soar After Merger Agreement With Paratek Pharmaceuticals: Retail Sentiment Takes Flight - MSN
Optinose to be acquired by Boston-based Paratek Pharmaceuticals in potential $330M deal - The Business Journals
Piper Sandler Downgrades OptiNose to Neutral From Overweight, $9 Price Target -March 20, 2025 at 12:32 pm EDT - Marketscreener.com
Finanzdaten der Optinose Inc-Aktie (OPTN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Optinose Inc-Aktie (OPTN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mahmoud Ramy A | Chief Executive Officer |
Mar 18 '25 |
Sale |
5.61 |
368 |
2,064 |
126,563 |
1.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):